Continuum Advisory, LLC

SEC CIK: 0001846532
Latest filing: Aug 6, 2026

SEC filings (opens in a new tab)

HALO holding history

Halozyme Therapeutics, Inc. in every 13F filed by Continuum Advisory, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

HALO overview All 13F holders of HALO Full Q2 2026 holdings

Shares (Q2 2026): 139
Value: $10.9K
% of portfolio: <0.1%
Quarters held: 3; Since Q1 2024

Holdings of HALO by Continuum Advisory, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	139	$10.9K	<0.1%	+139	New	Holders
Q3 2024	0	$0	0.0%	−28−100.0%	Sold out	Holders
Q2 2024	28	$1.47K	<0.1%	−43−60.6%	Reduced	Holders
Q1 2024	71	$3.11K	<0.1%	+71	New	Holders